Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for OmniAb, Inc. (OABI : NSDQ)

• Company Description    OmniAb Inc. discovery platform provides pharmaceutical industry partners access to the diverse antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. OmniAb Inc., formerly known as Avista Public Acquisition Corp. II, is based in SAN DIEGO. Number of Employees: 114

• Price / Volume Information    Yesterday's Closing Price: $1.60 Daily Weekly Monthly 20 Day Moving Average: 397,894 shares Shares Outstanding: 122.70 (millions) Market Capitalization: $196.32 (millions) Beta: 0.14 52 Week High: $4.87 52 Week Low: $1.22 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -20.00% -21.44% 12 Week -3.03% -11.96% Year To Date -54.80% -59.65%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 5980 Horton Street Suite 600 - Emeryville,CA 94608 USA ph: 510-250-7800 fax: - investors@omniab.com http://www.omniab.com

• General Corporate Information    Officers Matthew W. Foehr - President and Chief Executive Officer and Director John L. Higgins - Director and Chairman of the Board Kurt Gustafson - Executive Vice President; Finance and Chief Financ Carolyn R. Bertozzi - Director Sarah Boyce - Director Peer Information OmniAb, Inc. (GSAC) OmniAb, Inc. (CASI) OmniAb, Inc. (ALCD.) OmniAb, Inc. (OMNN) OmniAb, Inc. (CGPI.) OmniAb, Inc. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 68218J103 SIC: 8731 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/11/25 Share - Related Items Shares Outstanding: 122.70 Most Recent Split Date: (:1) Beta: 0.14 Market Capitalization: $196.32 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.15 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.60 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/11/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.75 Price/Cash Flow: - Price / Sales: 8.53 EPS Growth vs. Year Ago Period: -15.38% vs. Previous Quarter: 11.76% Sales Growth vs. Year Ago Period: -48.82% vs. Previous Quarter: -6.19% ROE 06/30/25 - -22.79 03/31/25 - -21.37 12/31/24 - -21.12 ROA 06/30/25 - -20.18 03/31/25 - -18.84 12/31/24 - -18.42 Current Ratio 06/30/25 - 3.77 03/31/25 - 4.70 12/31/24 - 4.52 Quick Ratio 06/30/25 - 3.77 03/31/25 - 4.70 12/31/24 - 4.52 Operating Margin 06/30/25 - -275.83 03/31/25 - -229.11 12/31/24 - -235.05 Net Margin 06/30/25 - -275.83 03/31/25 - -229.11 12/31/24 - -235.05 Pre-Tax Margin 06/30/25 - -296.89 03/31/25 - -254.78 12/31/24 - -270.59 Book Value 06/30/25 - 2.14 03/31/25 - 2.24 12/31/24 - 2.37 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - 0.00 03/31/25 - 0.00 12/31/24 - 0.00 Debt-to-Capital 06/30/25 - 0.00 03/31/25 - 0.00 12/31/24 - 0.00

Powered by Zacks Investment Research ©